KANZHUN LTD - ADR (BZ) Fundamental Analysis & Valuation

NASDAQ:BZ • US48553T1060

14.485 USD
-0.54 (-3.63%)
Last: Mar 11, 2026, 02:09 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This BZ fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

Taking everything into account, BZ scores 6 out of 10 in our fundamental rating. BZ was compared to 87 industry peers in the Professional Services industry. BZ is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. BZ may be a bit undervalued, certainly considering the very reasonable score on growth These ratings could make BZ a good candidate for value investing.


Dividend Valuation Growth Profitability Health

6

1. BZ Profitability Analysis

1.1 Basic Checks

  • BZ had positive earnings in the past year.
  • In the past year BZ had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: BZ reported negative net income in multiple years.
  • In the past 5 years BZ always reported a positive cash flow from operatings.
BZ Yearly Net Income VS EBIT VS OCF VS FCFBZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 10.31%, BZ belongs to the top of the industry, outperforming 82.76% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 12.92%, BZ is in the better half of the industry, outperforming 63.22% of the companies in the same industry.
  • The Return On Invested Capital of BZ (9.77%) is better than 66.67% of its industry peers.
Industry RankSector Rank
ROA 10.31%
ROE 12.92%
ROIC 9.77%
ROA(3y)5.02%
ROA(5y)-3.62%
ROE(3y)6.59%
ROE(5y)-5.82%
ROIC(3y)N/A
ROIC(5y)N/A
BZ Yearly ROA, ROE, ROICBZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

  • BZ has a better Profit Margin (31.09%) than 97.70% of its industry peers.
  • Looking at the Operating Margin, with a value of 26.94%, BZ belongs to the top of the industry, outperforming 94.25% of the companies in the same industry.
  • BZ has a Gross Margin of 84.53%. This is amongst the best in the industry. BZ outperforms 95.40% of its industry peers.
  • In the last couple of years the Gross Margin of BZ has remained more or less at the same level.
Industry RankSector Rank
OM 26.94%
PM (TTM) 31.09%
GM 84.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.49%
GM growth 5Y-0.72%
BZ Yearly Profit, Operating, Gross MarginsBZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. BZ Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BZ is still creating some value.
  • Compared to 1 year ago, BZ has less shares outstanding
  • Compared to 5 years ago, BZ has more shares outstanding
  • BZ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BZ Yearly Shares OutstandingBZ Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
BZ Yearly Total Debt VS Total AssetsBZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • BZ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC1.3
WACC7.54%
BZ Yearly LT Debt VS Equity VS FCFBZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

  • A Current Ratio of 4.18 indicates that BZ has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 4.18, BZ belongs to the best of the industry, outperforming 93.10% of the companies in the same industry.
  • BZ has a Quick Ratio of 4.18. This indicates that BZ is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of BZ (4.18) is better than 93.10% of its industry peers.
Industry RankSector Rank
Current Ratio 4.18
Quick Ratio 4.18
BZ Yearly Current Assets VS Current LiabilitesBZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5B 10B 15B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. BZ Growth Analysis

3.1 Past

  • BZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.62%, which is quite impressive.
  • BZ shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.66%.
  • BZ shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 49.09% yearly.
EPS 1Y (TTM)30.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%31.71%
Revenue 1Y (TTM)12.66%
Revenue growth 3Y19.98%
Revenue growth 5Y49.09%
Sales Q2Q%13.17%

3.2 Future

  • The Earnings Per Share is expected to decrease by -2.51% on average over the next years.
  • Based on estimates for the next years, BZ will show a quite strong growth in Revenue. The Revenue will grow by 11.34% on average per year.
EPS Next Y34.25%
EPS Next 2Y22.94%
EPS Next 3Y21.03%
EPS Next 5Y-2.51%
Revenue Next Year12.58%
Revenue Next 2Y12.88%
Revenue Next 3Y12.99%
Revenue Next 5Y11.34%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BZ Yearly Revenue VS EstimatesBZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 5B 10B 15B
BZ Yearly EPS VS EstimatesBZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

7

4. BZ Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 13.17, the valuation of BZ can be described as correct.
  • Based on the Price/Earnings ratio, BZ is valued a bit cheaper than 70.11% of the companies in the same industry.
  • BZ's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.25.
  • Based on the Price/Forward Earnings ratio of 11.04, the valuation of BZ can be described as reasonable.
  • Based on the Price/Forward Earnings ratio, BZ is valued a bit cheaper than the industry average as 73.56% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 24.39. BZ is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 13.17
Fwd PE 11.04
BZ Price Earnings VS Forward Price EarningsBZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BZ is valued cheaply inside the industry as 89.66% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, BZ is valued a bit cheaper than 75.86% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.09
EV/EBITDA 5.42
BZ Per share dataBZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • BZ has a very decent profitability rating, which may justify a higher PE ratio.
  • BZ's earnings are expected to grow with 21.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.38
PEG (5Y)N/A
EPS Next 2Y22.94%
EPS Next 3Y21.03%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

2

5. BZ Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.98%, BZ is not a good candidate for dividend investing.
  • The stock price of BZ dropped by -24.70% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • BZ's Dividend Yield is a higher than the industry average which is at 1.65.
  • With a Dividend Yield of 0.98, BZ pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.98%

5.2 History

  • BZ has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BZ Yearly Dividends per shareBZ Yearly Dividends per shareYearly Dividends per share 2023 2025 0.05 0.1 0.15

5.3 Sustainability

DPN/A
EPS Next 2Y22.94%
EPS Next 3Y21.03%
BZ Yearly Income VS Free CF VS DividendBZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

More info and screens

Find the best dividend stocksShow peers with best dividend

BZ Fundamentals: All Metrics, Ratios and Statistics

KANZHUN LTD - ADR

NASDAQ:BZ (3/11/2026, 2:09:56 PM)

14.485

-0.54 (-3.63%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)03-09
Earnings (Next)05-20
Inst Owners81.59%
Inst Owner Change-0.69%
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap6.75B
Revenue(TTM)8.01B
Net Income(TTM)2.49B
Analysts84.29
Price Target26.7 (84.33%)
Short Float %7.41%
Short Ratio4.6
Dividend
Industry RankSector Rank
Dividend Yield 0.98%
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.8%
Min EPS beat(2)1.34%
Max EPS beat(2)10.26%
EPS beat(4)3
Avg EPS beat(4)4.5%
Min EPS beat(4)-0.61%
Max EPS beat(4)10.26%
EPS beat(8)7
Avg EPS beat(8)7.78%
EPS beat(12)11
Avg EPS beat(12)266%
EPS beat(16)14
Avg EPS beat(16)207.5%
Revenue beat(2)0
Avg Revenue beat(2)-2.35%
Min Revenue beat(2)-3.08%
Max Revenue beat(2)-1.62%
Revenue beat(4)0
Avg Revenue beat(4)-2.34%
Min Revenue beat(4)-3.08%
Max Revenue beat(4)-1.62%
Revenue beat(8)0
Avg Revenue beat(8)-1.86%
Revenue beat(12)3
Avg Revenue beat(12)-1.32%
Revenue beat(16)4
Avg Revenue beat(16)-1.07%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.47%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 13.17
Fwd PE 11.04
P/S 5.79
P/FCF 11.09
P/OCF 11.09
P/B 2.41
P/tB 2.42
EV/EBITDA 5.42
EPS(TTM)1.1
EY7.59%
EPS(NY)1.31
Fwd EY9.06%
FCF(TTM)1.31
FCFY9.02%
OCF(TTM)1.31
OCFY9.02%
SpS2.5
BVpS6.02
TBVpS5.99
PEG (NY)0.38
PEG (5Y)N/A
Graham Number12.21
Profitability
Industry RankSector Rank
ROA 10.31%
ROE 12.92%
ROCE 11.13%
ROIC 9.77%
ROICexc 1069.68%
ROICexgc 2915.11%
OM 26.94%
PM (TTM) 31.09%
GM 84.53%
FCFM 52.23%
ROA(3y)5.02%
ROA(5y)-3.62%
ROE(3y)6.59%
ROE(5y)-5.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.49%
GM growth 5Y-0.72%
F-Score7
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 157.29%
Profit Quality 168.02%
Current Ratio 4.18
Quick Ratio 4.18
Altman-Z N/A
F-Score7
WACC7.54%
ROIC/WACC1.3
Cap/Depr(3y)260.87%
Cap/Depr(5y)288.66%
Cap/Sales(3y)11.74%
Cap/Sales(5y)9.69%
Profit Quality(3y)326.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%31.71%
EPS Next Y34.25%
EPS Next 2Y22.94%
EPS Next 3Y21.03%
EPS Next 5Y-2.51%
Revenue 1Y (TTM)12.66%
Revenue growth 3Y19.98%
Revenue growth 5Y49.09%
Sales Q2Q%13.17%
Revenue Next Year12.58%
Revenue Next 2Y12.88%
Revenue Next 3Y12.99%
Revenue Next 5Y11.34%
EBIT growth 1Y112.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year81.52%
EBIT Next 3Y33.45%
EBIT Next 5Y21.33%
FCF growth 1Y83.9%
FCF growth 3Y24.82%
FCF growth 5YN/A
OCF growth 1Y83.9%
OCF growth 3Y29.23%
OCF growth 5YN/A

KANZHUN LTD - ADR / BZ FAQ

What is the fundamental rating for BZ stock?

ChartMill assigns a fundamental rating of 6 / 10 to BZ.


Can you provide the valuation status for KANZHUN LTD - ADR?

ChartMill assigns a valuation rating of 7 / 10 to KANZHUN LTD - ADR (BZ). This can be considered as Undervalued.


What is the profitability of BZ stock?

KANZHUN LTD - ADR (BZ) has a profitability rating of 6 / 10.


What is the valuation of KANZHUN LTD - ADR based on its PE and PB ratios?

The Price/Earnings (PE) ratio for KANZHUN LTD - ADR (BZ) is 13.17 and the Price/Book (PB) ratio is 2.41.


How financially healthy is KANZHUN LTD - ADR?

The financial health rating of KANZHUN LTD - ADR (BZ) is 7 / 10.